HuffPost: Does the type of soap or hand sanitizer you use matter for coronavirus?
UC expert provides information for warding off COVID-19
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by the Huffington Post about how coronavirus is spread for a story about proper hand sanitation.
Dr. Carl Fichtenbaum working in a lab in the Division of Infectious Diseases at UC's College of Medicine.
According to medical experts, thorough hand washing is one of the key methods of warding off COVID-19. Dr. Fichtenbaum discussed how the virus is spread and said the type of soap or sanitizer used isn't as important as proper hand washing.
“There is no clear evidence that antibacterial soap works better than any other soap,” Fichtenbaum told HuffPost. “The most important thing is washing hands for at least 20 seconds, and then it is a combination of soap plus mechanical disruption that works [to rid hands of the virus].”
Read the entire story here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.